TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $214,000 | +13.2% | 14,995 | +30.2% | 0.02% | +21.1% |
Q3 2021 | $189,000 | +3.3% | 11,515 | +6.2% | 0.02% | +5.6% |
Q2 2021 | $183,000 | -6.6% | 10,844 | -4.7% | 0.02% | -21.7% |
Q1 2021 | $196,000 | -0.5% | 11,375 | +2.3% | 0.02% | -4.2% |
Q4 2020 | $197,000 | +5.9% | 11,116 | +4.8% | 0.02% | -45.5% |
Q1 2020 | $186,000 | -12.3% | 10,607 | +0.5% | 0.04% | 0.0% |
Q4 2019 | $212,000 | +1.0% | 10,557 | +0.4% | 0.04% | -4.3% |
Q3 2019 | $210,000 | +14.1% | 10,510 | -2.1% | 0.05% | +7.0% |
Q2 2019 | $184,000 | -13.6% | 10,737 | +1.6% | 0.04% | -23.2% |
Q4 2018 | $213,000 | – | 10,563 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |